This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
ReWalk Robotics (LFWD) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
ReWalk (LFWD) delivered earnings and revenue surprises of 5.66% and 0.05%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
The Oncology Institute, Inc. (TOI) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
The Oncology Institute (TOI) delivered earnings and revenue surprises of -70% and 4.58%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Taysha Gene Therapies, Inc. (TSHA) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Taysha Gene Therapies (TSHA) delivered earnings and revenue surprises of 10% and 69.28%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Sharecare, Inc. (SHCR) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sharecare (SHCR) delivered earnings and revenue surprises of -33.33% and 4.55%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
CoDiagnostics (CODX) delivered earnings and revenue surprises of 26.47% and 564.25%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Surgery Partners (SGRY) Meets Q2 Earnings Estimates
by Zacks Equity Research
Surgery Partners (SGRY) delivered earnings and revenue surprises of 0% and 3.99%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Bausch + Lomb (BLCO) Matches Q2 Earnings Estimates
by Zacks Equity Research
Bausch + Lomb (BLCO) delivered earnings and revenue surprises of 0% and 4.11%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Alignment Healthcare (ALHC) Surges 11.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Alignment Healthcare (ALHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Here's What Key Metrics Tell Us About Premier (PINC) Q3 Earnings
by Zacks Equity Research
Although the revenue and EPS for Premier (PINC) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Premier, Inc. (PINC) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Premier (PINC) delivered earnings and revenue surprises of 17.02% and 9.48%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?